{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:02:50Z","timestamp":1793059370398,"version":"4.5.0"},"reference-count":33,"publisher":"American Diabetes Association","issue":"6","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,6,1]]},"abstract":"<jats:p>OBJECTIVE\u2014To examine by meta-analysis the relationship between cardiovascular autonomic neuropathy (CAN) and risk of mortality in individuals with diabetes.<\/jats:p>\n                  <jats:p>RESEARCH DESIGN AND METHODS\u2014We searched Medline for English-language articles published from 1966 to 2001. Fifteen studies having a baseline assessment of cardiovascular autonomic function and mortality follow-up were identified. The analyses were stratified according to whether a single abnormality or two or more measures of cardiovascular autonomic function were used to define CAN. A global measure of association (i.e., relative risk) was generated for each group by pooling estimates across the studies using the Mantel-Haenszel procedure.<\/jats:p>\n                  <jats:p>RESULTS\u2014CAN was significantly associated with subsequent mortality in both groups, although the magnitude of the association was stronger for those studies for which two or more measures were used to define CAN. The pooled relative risk for studies that defined CAN with the presence of two or more abnormalities was 3.45 (95% CI 2.66\u20134.47; P &amp;lt; 0.001) compared with 1.20 (1.02\u20131.41; P = 0.03) for studies that used one measure.<\/jats:p>\n                  <jats:p>CONCLUSIONS\u2014These results support an association between CAN and increased risk of mortality. The stronger association observed in studies defining CAN by the presence of two or more abnormalities may be due to more severe autonomic dysfunction in these subjects or a higher frequency of other comorbid complications that contributed to their higher mortality risk. Future studies should evaluate whether early identification of subjects with CAN can lead to a reduction in mortality.<\/jats:p>","DOI":"10.2337\/diacare.26.6.1895","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T17:51:27Z","timestamp":1173117087000},"page":"1895-1901","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":578,"title":["The Association Between Cardiovascular Autonomic Neuropathy and Mortality in Individuals With Diabetes"],"prefix":"10.2337","volume":"26","author":[{"given":"Raelene E.","family":"Maser","sequence":"first","affiliation":[{"name":"Department of Medical Technology, University of Delaware, Newark, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braxton D.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes & Nutrition, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron I.","family":"Vinik","sequence":"additional","affiliation":[{"name":"Department of Medicine and Pathology\/Anatomy\/Neurobiology, the Strelitz Diabetes Institutes, Eastern Virginia Medical School, Norfolk, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Freeman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031217343796700_R1","doi-asserted-by":"crossref","unstructured":"Maser RE, Lenhard MJ, DeCherney GS: Cardiovascular autonomic neuropathy: the clinical significance of its determination. Endocrinologist\u200810: 27\u201333, 2000","DOI":"10.1097\/00019616-200010010-00006"},{"key":"2022031217343796700_R2","unstructured":"Freeman R: Cardiovascular autonomic neuropathy. In Diabetic Neuropathy. 2nd ed. Dyck PJ, Thomas PK, Eds. Philadelphia, W.B. Saunders, 1999, p. 541\u2013554"},{"key":"2022031217343796700_R3","unstructured":"Hilsted J, Low PA: Diabetic autonomic neuropathy. In Clinical Autonomic Disorders. 2nd ed. Low PA, Ed. Philadelphia, Lippincott-Raven, 1997, p. 487\u2013508"},{"key":"2022031217343796700_R4","unstructured":"Ziegler D: Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev\u20087: 300\u2013315, 1999"},{"key":"2022031217343796700_R5","unstructured":"Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med\u200849: 95\u2013108, 1980"},{"key":"2022031217343796700_R6","doi-asserted-by":"crossref","unstructured":"Orchard TJ, Lloyd CE, Maser RE, Kuller LH: Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract\u200834 (Suppl.): S165\u2013S171, 1996","DOI":"10.1016\/S0168-8227(96)90025-X"},{"key":"2022031217343796700_R7","doi-asserted-by":"crossref","unstructured":"Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years\u2019 experience in diabetes. Diabetes Care\u20088: 491\u2013498, 1985","DOI":"10.2337\/diacare.8.5.491"},{"key":"2022031217343796700_R8","unstructured":"Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst\u200822: 719\u2013748, 1959"},{"key":"2022031217343796700_R9","unstructured":"Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ: Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med\u200875: 635\u2013646, 1990"},{"key":"2022031217343796700_R10","unstructured":"O\u2019Brien IA, McFadden JP, Corrall RJM: The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med\u200879: 495\u2013502, 1991"},{"key":"2022031217343796700_R11","doi-asserted-by":"crossref","unstructured":"Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF: Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia\u200834: 182\u2013185, 1991","DOI":"10.1007\/BF00418273"},{"key":"2022031217343796700_R12","unstructured":"Jermendy G, Toth L, Voros P, Koltai MZ, Pogatsa G: Cardiac autonomic neuropathy and QT interval length: a follow-up study in diabetic patients. Acta Cardiol\u200846: 189\u2013200, 1991"},{"key":"2022031217343796700_R13","doi-asserted-by":"crossref","unstructured":"Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA: Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med\u200810: 820\u2013824, 1993","DOI":"10.1111\/j.1464-5491.1993.tb00173.x"},{"key":"2022031217343796700_R14","doi-asserted-by":"crossref","unstructured":"Hathaway DK, El-Gebely S, Cardoso SS, Elmer DS, Gaber AO: Autonomic cardiac dysfunction in diabetic transplant recipients succumbing to sudden cardiac death. Transplantation\u200859: 634\u2013637, 1995","DOI":"10.1097\/00007890-199559040-00034"},{"key":"2022031217343796700_R15","doi-asserted-by":"crossref","unstructured":"Navarro X, Kennedy WR, Aeppli D, Sutherland DER: Neuropathy and mortality in diabetes: influence of pancreas transplantation. Muscle Nerve\u200819: 1009\u20131016, 1996","DOI":"10.1002\/(SICI)1097-4598(199608)19:8<1009::AID-MUS9>3.0.CO;2-4"},{"key":"2022031217343796700_R16","doi-asserted-by":"crossref","unstructured":"Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P for the Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate: QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study. Diabetes Care\u200823: 1381\u20131383, 2000","DOI":"10.2337\/diacare.23.9.1381"},{"key":"2022031217343796700_R17","doi-asserted-by":"crossref","unstructured":"Chen HS, Hwu CM, Kuo BI, Chiang SC, Kwok CF, Lee SH, Lee YS, Weih MJ, Hsiao LC, Lin SH, Ho LT: Abnormal cardiovascular reflex tests are predictors of mortality in type 2 diabetes mellitus. Diabet Med\u200818: 268\u2013273, 2001","DOI":"10.1046\/j.1464-5491.2001.00442.x"},{"key":"2022031217343796700_R18","doi-asserted-by":"crossref","unstructured":"Sawicki PT, Dahne R, Bender R, Berger M: Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia\u200839: 77\u201381, 1996","DOI":"10.1007\/BF00400416"},{"key":"2022031217343796700_R19","doi-asserted-by":"crossref","unstructured":"Toyry JP, Niskanen LK, Mantysaari MJ, Lansimies EA, Uusitupa MIJ: Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM: ten-year follow-up from the diagnosis. Diabetes\u200845: 308\u2013315, 1996","DOI":"10.2337\/diabetes.45.3.308"},{"key":"2022031217343796700_R20","doi-asserted-by":"crossref","unstructured":"Sawicki PT, Kiwitt S, Bender R, Berger M: The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med\u2008243: 49\u201356, 1998","DOI":"10.1046\/j.1365-2796.1998.00259.x"},{"key":"2022031217343796700_R21","doi-asserted-by":"crossref","unstructured":"Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CDA: Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care\u200824: 1793\u20131798, 2001","DOI":"10.2337\/diacare.24.10.1793"},{"key":"2022031217343796700_R22","doi-asserted-by":"crossref","unstructured":"Wirta O, Pasternack A, Mustonen J, Laippala P: Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-dependent diabetic subjects. Nephrol Dial Transplant\u200812: 2612\u20132617, 1997","DOI":"10.1093\/ndt\/12.12.2612"},{"key":"2022031217343796700_R23","doi-asserted-by":"crossref","unstructured":"Levitt NS, Stansberry KB, Wynchank S, Vinik AI: The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM. Diabetes Care\u200819: 751\u2013754, 1996","DOI":"10.2337\/diacare.19.7.751"},{"key":"2022031217343796700_R24","doi-asserted-by":"crossref","unstructured":"Reichard P, Pihl M: Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes\u200843: 313\u2013317, 1994","DOI":"10.2337\/diabetes.43.2.313"},{"key":"2022031217343796700_R25","doi-asserted-by":"crossref","unstructured":"Charlson ME, MacKenzie CR, Gold JP: Preoperative autonomic function abnormalities in patients with diabetes mellitus and patients with hypertension. J Am Coll Surg\u2008179: 1\u201310, 1994","DOI":"10.1097\/00132586-199502000-00075"},{"key":"2022031217343796700_R26","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia\u200841: 416\u2013423, 1998","DOI":"10.1007\/s001250050924"},{"key":"2022031217343796700_R27","doi-asserted-by":"crossref","unstructured":"Gaede P, Vedel P, Parving HH, Pedersen O: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomized study. Lancet\u2008353: 617\u2013622, 1999","DOI":"10.1016\/S0140-6736(98)07368-1"},{"key":"2022031217343796700_R28","doi-asserted-by":"crossref","unstructured":"Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Prac\u200828: 103\u2013117, 1995","DOI":"10.1016\/0168-8227(95)01064-K"},{"key":"2022031217343796700_R29","doi-asserted-by":"crossref","unstructured":"Ebbehoj E, Poulsen PL, Hansen KW, Knudsen ST, Molgaard H, Mogensen CE: Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in type 1 diabetic patients with abnormal albuminuria. Diabeteologia\u200845: 965\u2013975, 2002","DOI":"10.1007\/s00125-002-0869-7"},{"key":"2022031217343796700_R30","doi-asserted-by":"crossref","unstructured":"Malik RA, Williamson S, Abbott C, Carrington AL, Iqbal J, Schady W, Boulton AJM: Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomized double-blind controlled trial. Lancet\u2008352: 1978\u20131981, 1998","DOI":"10.1016\/S0140-6736(98)02478-7"},{"key":"2022031217343796700_R31","doi-asserted-by":"crossref","unstructured":"Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC, Karamitsos DT: Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care\u200820: 355\u2013361, 1997","DOI":"10.2337\/diacare.20.3.355"},{"key":"2022031217343796700_R32","doi-asserted-by":"crossref","unstructured":"Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, DEKAN Study Group, Reichel G: Effects of treatment with the antioxidant \u03b1-lipoic acid on cardiac autonomic neuropathy in NIDDM patients: a 4-month randomized controlled multicenter trial (DEKAN Study). Diabetes Care\u200820: 369\u2013373, 1997","DOI":"10.2337\/diacare.20.3.369"},{"key":"2022031217343796700_R33","doi-asserted-by":"crossref","unstructured":"Vinik AI, Erbas T: Recognizing and treating diabetic autonomic neuropathy. Cleveland Clinic J Med\u200868: 928\u2013944, 2001","DOI":"10.3949\/ccjm.68.11.928"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/6\/1895\/591627\/dc0603001895.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/6\/1895\/591627\/dc0603001895.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T13:26:26Z","timestamp":1647091586000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/26\/6\/1895\/26327\/The-Association-Between-Cardiovascular-Autonomic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.26.6.1895","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,1]]}}}